ABSTRACT
The Harvard-Emory ECG Database (HEEDB) is a large collection of 12-lead electrocardiogram (ECG) recordings, developed through a collaboration between Harvard University and Emory University. The database consists of 10,608,417 unique ECG recordings from 1,818,247 patients from Massachusetts General Hospital (MGH) and 1,452,964 recordings from 552,481 patients from Emory University Hospital (EUH) collected in clinical settings as part of routine patient care since the early 1990s. Continuously updated with new data, the recordings consist of 10-second, 12-lead ECGs sampled at 250 and 500 Hz, and stored in WFDB format. Future updates will include demographic information such as age, sex, race, and ethnicity. Additionally, 12SL annotations–encompassing ECG diagnoses, morphology, and rhythms–are available for 10,471,531 recordings from MGH and 1,268,277 recordings from EUH. Shortly, ICD-9/10 codes, CPT codes, and medication history will also be made publicly available.
Competing Interest Statement
M.B.W. is a co-founder, scientific advisor, and consultant to Beacon Biosignals and has a personal equity interest in the company. D.E.A. is the founder and Chief Medical Officer of AliveCor Inc. and holds personal equity in the company. J.X. is a research fellow at Alivecor Inc. and also holds personal equity in the company. G.D.C. holds significant stock in AliveCor Inc. The other authors report no competing interests.
Funding Statement
Publication of HEEDB is supported by a grant (R01HL161253) from the National Heart Lung and Blood Institute (NHLBI) of the NIH. Publication of the HEEDB is also supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under NIH grant number R01EB030362, and an unrestricted funds from Emory University. Q.L., M.R. and G.D.C. are supported in part by unrestricted funding from AliveCor Inc.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Emory University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵† co-senior authors
We updated the license to: CC BY-NC-ND
Data Availability
All data produced are available online with credentialed access at https://bdsp.io/content/heedb/1.0/ and shortly will be available publicly.
